The Biggest Psychedelic News This Week – October 9th
Weekly psychedelic news: Psychedelics could treat OCD, Novartis abandons study and Cybin Inc moves to acquire Small Pharma
Weekly psychedelic news: Psychedelics could treat OCD, Novartis abandons study and Cybin Inc moves to acquire Small Pharma
Psychedelic news: PTSD treatments, Esketamine’s efficacy, Eureka’s decrim, and PsyCan’s proposal. Stay informed on the latest updates.
Psychedelic News: California’s Bill 58 updates, SSRIs and DMT for depression, Maine’s pivotal moments, and Brazil’s opinions on psychedelics.
Psychedelic News Surge: Massachusetts’ Plant Medicine Dive, Kentucky’s Ibogaine Initiative, Pain-Relieving Potential, and Ketamine’s Pediatric Promise
2023 has already shown extensive advances in the realm of psychedelic policy reform
This week on the Psychedelic Spotlight podcast, we talk with Sam Chapman. Sam is a resident of Portland, Oregon, he was the Campaign Manager for Oregon Measure 109, and is now the Executive Director of the Healing Advocacy Fund, a nonprofit organization dedicated to supporting the nation’s first regulated psilocybin therapy program.
Michigan could follow in the steps of Oregon to legalize psychedelics for therapeutic use. Ann Arbor already decriminalizes possession.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.